Media

Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m – HealthCap and Hadean Growth Fund Join Strong Investor Syndicate

BONESUPPORT HOLDING AB (publ) – publishes Q2 2025 Interim report

Blended care for mental health: HelloBetter and Generali Health Solutions launch innovative care partnership

Oncopeptides announces net sales for Q2 2025

Oncopeptides’ drug Pepaxti included in European Guidelines for the treatment of multiple myeloma

Oncorena’s new issue of shares fully subscribed

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center

Hemab Therapeutics Presents Positive Clinical and Preclinical Data Across Bleeding Disorder Pipeline at ISTH 2025 Congress

Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program

Precirix Submits Investigational New Drug (IND) Application to FDA forCAM-FAP-Ac-225, a Novel Radiopharmaceutical Targeting FibroblastActivation Protein (FAP)